News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,890 Results
Type
Article (2843)
Company Profile (24)
Press Release (95023)
Section
Business (39390)
Career Advice (50)
Deals (6128)
Drug Delivery (5)
Drug Development (12407)
Employer Resources (9)
FDA (1852)
Job Trends (2149)
News (57879)
Policy (3573)
Tag
Academia (218)
Adcomms (1)
Allergies (16)
Alliances (5128)
ALS (11)
Alzheimer's disease (216)
Antibody-drug conjugate (ADC) (17)
Approvals (1920)
Artificial intelligence (26)
Autoimmune disease (3)
Automation (1)
Bankruptcy (27)
Best Places to Work (1987)
BIOSECURE Act (1)
Biosimilars (13)
Biotechnology (13)
Bladder cancer (18)
Brain cancer (3)
Breast cancer (74)
Cancer (559)
Cardiovascular disease (21)
Career advice (44)
Career pathing (2)
CAR-T (21)
CDC (1)
Cell therapy (67)
Cervical cancer (6)
Clinical research (11019)
Collaboration (122)
Compensation (36)
COVID-19 (275)
CRISPR (7)
C-suite (42)
Cystic fibrosis (23)
Data (693)
Depression (8)
Diabetes (32)
Diagnostics (1089)
Digital health (6)
Diversity, equity & inclusion (3)
Drug discovery (16)
Drug pricing (5)
Drug shortages (1)
Duchenne muscular dystrophy (25)
Earnings (30795)
Editorial (4)
Employer branding (3)
Employer resources (9)
Events (12345)
Executive appointments (62)
FDA (2186)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (112)
Gene editing (12)
Generative AI (2)
Gene therapy (40)
GLP-1 (104)
Government (368)
Grass and pollen (1)
Guidances (118)
Healthcare (2668)
HIV (6)
Huntington's disease (1)
IgA nephropathy (11)
Immunology and inflammation (9)
Immuno-oncology (1)
Indications (12)
Infectious disease (301)
Inflammatory bowel disease (31)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (11)
Interviews (6)
IPO (4157)
IRA (3)
Job creations (270)
Job search strategy (39)
Kidney cancer (3)
Labor market (8)
Layoffs (40)
Legal (534)
Liver cancer (10)
Longevity (1)
Lung cancer (79)
Lymphoma (65)
Management (2)
Manufacturing (41)
MASH (20)
Medical device (2167)
Medtech (2167)
Mergers & acquisitions (2084)
Metabolic disorders (83)
Multiple sclerosis (29)
NASH (2)
Neurodegenerative disease (7)
Neuropsychiatric disorders (2)
Neuroscience (312)
NextGen: Class of 2025 (674)
Non-profit (282)
Now hiring (1)
Obesity (32)
Opinion (11)
Ovarian cancer (26)
Pain (16)
Pancreatic cancer (17)
Parkinson's disease (22)
Partnered (1)
Patents (26)
Patient recruitment (20)
Peanut (10)
People (4267)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (2728)
Phase II (4569)
Phase III (4393)
Pipeline (696)
Policy (7)
Postmarket research (477)
Preclinical (878)
Press Release (1)
Prostate cancer (32)
Psychedelics (1)
Radiopharmaceuticals (49)
Rare diseases (68)
Real estate (574)
Recruiting (3)
Regulatory (3011)
Reports (17)
Research institute (226)
Resumes & cover letters (5)
RSV (11)
Schizophrenia (16)
Series A (18)
Series B (14)
Service/supplier (1)
Sickle cell disease (10)
Special edition (2)
Spinal muscular atrophy (17)
Startups (284)
Stomach cancer (3)
Supply chain (6)
Tariffs (1)
Vaccines (81)
Venture capital (4)
Weight loss (17)
Women's health (2)
Worklife (2)
Date
Today (14)
Last 7 days (49)
Last 30 days (205)
Last 365 days (5623)
2025 (2918)
2024 (6699)
2023 (7759)
2022 (8650)
2021 (9090)
2020 (7985)
2019 (7320)
2018 (5339)
2017 (5230)
2016 (3930)
2015 (5078)
2014 (3528)
2013 (2481)
2012 (3290)
2011 (3231)
2010 (2711)
Location
Africa (59)
Alabama (7)
Alaska (1)
Arizona (19)
Arkansas (2)
Asia (4854)
Australia (799)
California (1047)
Canada (323)
China (90)
Colorado (54)
Connecticut (45)
Delaware (45)
Europe (28059)
Florida (115)
Georgia (34)
Idaho (3)
Illinois (73)
India (6)
Indiana (103)
Japan (69)
Kansas (32)
Kentucky (11)
Louisiana (4)
Maine (16)
Maryland (184)
Massachusetts (910)
Michigan (32)
Minnesota (117)
Missouri (12)
Montana (6)
Nebraska (4)
Nevada (14)
New Hampshire (18)
New Jersey (539)
New York (384)
North Carolina (177)
Northern California (522)
Ohio (31)
Pennsylvania (296)
Rhode Island (2)
South America (105)
South Carolina (3)
Southern California (368)
Tennessee (6)
Texas (132)
United States (4543)
Utah (56)
Virginia (11)
Washington D.C. (6)
Washington State (114)
Wisconsin (12)
97,890 Results for "44".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Radiopharmaceuticals Market Size Worth USD 14.44 Billion by 2034
June 23, 2025
·
1 min read
Press Releases
Cell Line Development Market Grows to USD 6.44 Billion in 2025 Amid CRISPR, AI and Biosimilar Expansion
July 3, 2025
·
1 min read
Press Releases
Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44
February 24, 2025
·
7 min read
Press Releases
CircRNA Synthesis Market Size to Surpass USD 805.44 Million by 2034
February 18, 2025
·
1 min read
Press Releases
Cell and Gene Therapy Market Size to Surge USD 187.44 Billion by 2034
February 20, 2025
·
1 min read
BioMidwest
Neogen® to Participate in the 44th Annual William Blair Growth Stock Conference
Neogen announced today that the Company will participate in the 44th Annual William Blair Growth Stock Conference in Chicago, Illinois, on Tuesday, June 4, 2024.
May 30, 2024
·
1 min read
Press Releases
U.S. Anesthesia and Respiratory Devices Market Size to Hit USD 17.44 Bn by 2034
February 25, 2025
·
1 min read
Press Releases
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living with Duchenne Muscular Dystrophy
February 3, 2025
·
8 min read
Pharm Country
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
Neuronetics, Inc. today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Thursday, June 6, 2024.
May 23, 2024
·
1 min read
Press Releases
Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis
May 14, 2025
·
5 min read
1 of 9,789
Next
